Adherence Improvement in Glaucoma Patients

Maastricht University Medical Centre (MUMC)

Status: Completed

Conditions: Glaucoma

Treatments: Device: Use of TravAlert dosing aid with or without drop guider

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00603005

CTCM-071015

MEC 07-1-015

Details and patient eligibility

About

The purpose of this study is to study the effect on intraocular pressure in glaucoma patients using the TravAlert dosing aid with or without the Eyot drop guider and with or without additional patient education.

Enrollment: 802 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis glaucoma or ocular hypertension
• Treatment with travoprost or travoprost/timolol

Exclusion criteria

• High risk of side effects expected from travoprost or travoprost/timolol
• Absolute inability to administer eye drops
• Difficulty in reading or speaking Dutch

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: Single Blind

---

802 participants in 4 patient groups

1

Experimental group

Treatment:

Device: Use of TravAlert dosing aid with or without drop guider

2

Experimental group

Treatment:

Device: Use of TravAlert dosing aid with or without drop guider

3

Experimental group

Treatment:

Device: Use of TravAlert dosing aid with or without drop guider

4

Experimental group

Treatment:

Device: Use of TravAlert dosing aid with or without drop guider